Skip to content
Clinical Trials – home

Finnish Institute For Health And Welfare

Research site

Finland Mannerheimintie 166, 00300 Helsinki, Finland

  • 1 trial recruiting
  • Influenza · Avian influenza · Bacterial infection
  • Adult patients

About Specializations

Finnish Institute For Health And Welfare in Helsinki, Finland specialises in clinical trials of conditions such as Influenza, Avian influenza, Bacterial infection, COVID-19, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases and Virus Diseases

At the Finnish Institute For Health And Welfare in Helsinki, clinical research focuses on viral infections that affect the respiratory system, with work centered on influenza, avian influenza, and COVID-19. The studies are designed to better understand how the immune system responds to infection and vaccination, supporting improved prevention strategies and public health protection.

  • Assessing influenza immunity by measuring antibody responses before and after vaccination
  • Studying immune responses to a customized avian influenza vaccine against emerging strains
  • Evaluating immune responses after COVID-19 vaccination with different vaccine formulations

These trials help clarify how well vaccines stimulate protection against circulating viral threats and may inform future vaccine development and disease control efforts.

Influenza Immunology and Vaccine Response Research

This research area examines how people respond to seasonal and pandemic influenza vaccines, with a strong emphasis on antibody activity and broader immune protection. The work includes studies involving healthcare personnel and other participants to see how vaccination affects defense against current virus strains.

  • Measuring antibodies against circulating and vaccine influenza strains
  • Tracking humoral and cell-mediated immunity after vaccination
  • Exploring protection against seasonal influenza and related viral disease

These investigations aim to improve understanding of vaccine effectiveness and the body’s defense against changing influenza viruses.

COVID-19 and Emerging Viral Disease Studies

Another major focus at this site is immune response research related to COVID-19 infection and vaccination. The trials look at how different vaccine formulations influence the body’s ability to build protective immunity, contributing to ongoing efforts in viral disease preparedness.

  • Evaluating immune responses after COVID-19 vaccination
  • Comparing protection generated by different vaccine formulations
  • Supporting research on virus diseases and public health response

By studying vaccine-induced immunity, the research helps strengthen knowledge about preventing infection and improving responses to future outbreaks.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Mannerheimintie 16600300 HelsinkiFinland
Recruiting now
1 trial
Conditions studied
6

More sites in HelsinkiFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Influenza+1

Recruiting

Study on Immune Responses to Avian Influenza Vaccine with A/Turkey/Turkey/1/05 (H5N1)-Like Strain in Patients with Avian and Seasonal Influenza

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:A/TURKEY/TURKEY/1/05 (H5N1)-LIKE STRAIN (NIBRG-23)
  • Sponsor:Finnish Institute For Health And Welfare

COVID-19

Not recruiting

Study on Immune Responses to COVID-19 Vaccines: Raxtozinameran, Bretovameran, and Drug Combination for COVID-19 Patients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Bretovameran
  • Sponsor:Finnish Institute For Health And Welfare

Bacterial infection+3

Not recruiting

Study on Immune Responses to Influenza Vaccines in Health Care Workers Using Polysorbate 80, Sodium Citrate, and Citric Acid Anhydrous

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Polysorbate 80
  • Sponsor:Finnish Institute For Health And Welfare
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.